• 4260 Citations
  • 32 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Schizophrenia Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Psychotic Disorders Medicine & Life Sciences
Prefrontal Cortex Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cognition Medicine & Life Sciences
Hallucinations Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2017

Research Output 1989 2019

Targeting reduced neural oscillations in patients with schizophrenia by transcranial alternating current stimulation

Ahn, S., Mellin, J. M., Alagapan, S., Alexander, M. L., Gilmore, J. H., Jarskog, L. & Fröhlich, F., Feb 1 2019, In : NeuroImage. 186, p. 126-136 11 p.

Research output: Contribution to journalArticle

Hallucinations
Electroencephalography
Schizophrenia
Transcranial Direct Current Stimulation
Controlled Clinical Trials

Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia

Kraus, M. S., Walker, T. M., Jarskog, L., Millet, R. A. & Keefe, R. S. E., Jan 1 2018, (Accepted/In press) In : Schizophrenia research.

Research output: Contribution to journalArticle

Schizophrenia
Emotions
Aptitude
Recognition (Psychology)
Cognition
compound A 12
Oxytocin
Schizophrenia
Randomized Controlled Trials
Neuropeptides

Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ)

Lanser, I., Browne, J., Pinkham, A. E., Harvey, P. D., Jarskog, L. F. & Penn, D. L., Nov 1 2018, In : Psychiatry Research. 269, p. 38-44 7 p.

Research output: Contribution to journalArticle

Schizophrenia
Cognition
Social Skills
Surveys and Questionnaires
Psychometrics

Naltrexone and Bupropion combination treatment for smoking cessation and weight loss in patients with schizophrenia

Lyu, X., Du, J., Zhan, G., Wu, Y., Su, H., Zhu, Y., Jarskog, F., Zhao, M. & Fan, X., Mar 5 2018, In : Frontiers in Pharmacology. 9, MAR, 181.

Research output: Contribution to journalArticle

Bupropion
Naltrexone
Smoking Cessation
Weight Loss
Schizophrenia